Guosen Securities(SZ:002736) Morningstar晨星·2025-12-11 01:05Core Viewpoint - The article discusses the launch of the "Xinzhi Diagnosis" tool by Guosen Securities in collaboration with Morningstar, aimed at addressing the challenges faced by investors in managing their mutual fund accounts, particularly the issue of "pre-investment enthusiasm and post-investment coldness" [1]. Group 1: Pain Points - Traditional fund diagnostics are limited to individual product performance reviews, failing to assess risk and allocation from an overall account perspective. The "Xinzhi Diagnosis" tool effectively addresses the difficulty of account analysis [3]. - The tool allows for one-click aggregation of all holdings, enabling investors to conveniently and accurately summarize their mutual fund holdings across the market, thus achieving a comprehensive overview of personal fund assets [5]. - It provides in-depth analysis of underlying assets, utilizing Morningstar's global database to identify and penetrate the underlying holdings of users, rather than simply aggregating based on fund categories [6]. Group 2: Professional Empowerment - The "Xinzhi Diagnosis" tool leverages the KYP (Know Your Portfolio) module from Morningstar's advisory solutions, which includes two core capabilities: - Morningstar's holding transparency analysis, which offers multi-dimensional data analysis [8]. - Synchronization with personal E-accounts to enable comprehensive platform-wide holding analysis [10]. Group 3: Value Creation - The collaboration between Morningstar and Guosen Securities aims to explore a new model for post-sale service in public mutual funds. By combining Morningstar's innovative tools with Guosen's professional team, the service enhances the value chain from product to solution to service [12]. - This service is designed from the buyer's perspective, allowing investors to navigate the challenges and difficulties encountered during the fund investment process with greater ease [12].